Pharma Partnership Stock Tracking

This page is under construction. It is intended to track all pharmaceutical partnership related activities starting on July 7. 

***7/11 BDSI licensing agreement with Purdue Pharma

BioDelivery Sciences (BDSI) Enters Agreement With Purdue Pharma (Canada) For Licensing And Distribution Rights Of BELBUCA
***7/11 ABZA licensing agreement with OBI

Abzena and OBI Pharma Sign ThioBridge™ Licence Agreement
***7/11 cytovia (IMNP oncology subsidiary) licensing agreement with Pint Pharma

Immune Pharma (IMNP) Subsidiary Enters into Definitive Agreement with Pint Pharma for Licensing and Commercialization of Ceplene in Latin America
*** 7/10 CAPR DMD focused clinical stage company has ended partnership with JnJ/Janssen

J&J did not exercise option on Capricor Stem Cell Partnership
* ** 7/10 OPHT: Licensing agreement halt

Novartis hits pause on Fovista agreement

Due to lack of effectiveness shown so far for treatment of anti PDGF in wet amd.

***Zealand Pharma: Helsinn Healthcare 7/6/2017

License Agreement Between Zealand Pharma a/S and Helsinn Healthcare Sa

***CNAT: Novartis : 7/7/2017

Conatus Pharma Announces Effectiveness Of Exclusive License For Global Development And Commercialization Of Emricasan With Receipt Of $7 Million Payment